These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31448523)

  • 1. Authors' response to letter to the editor: Safety concerns with human papilloma virus immunization in Japan: Analysis and evaluation of Nagoya City's surveillance data for adverse events.
    Yaju Y; Tsubaki H
    Jpn J Nurs Sci; 2019 Oct; 16(4):503-506. PubMed ID: 31448523
    [No Abstract]   [Full Text] [Related]  

  • 2. Authors' response to letter to the editor, letter to the editor: Authors' response to letter to the editor: Safety concerns with human papilloma virus immunization in Japan: Analysis and evaluation of Nagoya City's surveillance data for adverse events.
    Yaju Y; Tsubaki H
    Jpn J Nurs Sci; 2020 Jan; 17(1):e12310. PubMed ID: 31788952
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter to the Editor: Authors' response to letter to the Editor: Safety concerns with human papilloma virus immunization in Japan: Analysis and evaluation of Nagoya City's surveillance data for adverse events.
    Suzuki S
    Jpn J Nurs Sci; 2020 Jan; 17(1):e12309. PubMed ID: 31788949
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter to the editor: Safety concerns with human papilloma virus immunization in Japan: Analysis and evaluation of Nagoya City's surveillance data for adverse events.
    Suzuki S
    Jpn J Nurs Sci; 2019 Oct; 16(4):500-502. PubMed ID: 31450266
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety concerns with human papilloma virus immunization in Japan: Analysis and evaluation of Nagoya City's surveillance data for adverse events.
    Yaju Y; Tsubaki H
    Jpn J Nurs Sci; 2019 Oct; 16(4):433-449. PubMed ID: 30693675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editor's Reply to the Letter to the Editor of Dr. Suzuki.
    Holzemer WL
    Jpn J Nurs Sci; 2019 Oct; 16(4):507-508. PubMed ID: 31448874
    [No Abstract]   [Full Text] [Related]  

  • 7. Allergic reactions to Japanese encephalitis vaccine.
    Plesner AM
    Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice.
    Nishiyama Y; Fujii T; Kanatani Y; Shinmura Y; Yokote H; Hashizume S
    Vaccine; 2015 Nov; 33(45):6120-7. PubMed ID: 26455406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiments on the cause of the rabbit carcinomas derived from virus-induced papillomas. II. Loss by the Vx2 carcinoma of the power to immunize hosts against the papilloma virus.
    ROUS P; KIDD JG; SMITH WE
    J Exp Med; 1952 Aug; 96(2):159-74. PubMed ID: 14955572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse events following HPV vaccination, Alberta 2006-2014.
    Liu XC; Bell CA; Simmonds KA; Svenson LW; Russell ML
    Vaccine; 2016 Apr; 34(15):1800-5. PubMed ID: 26921782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter to editor: Current and future techniques for human papilloma virus (HPV) testing in oropharyngeal squamous cell carcinoma.
    Qureishi A; Winter S
    Eur Arch Otorhinolaryngol; 2017 Dec; 274(12):4259. PubMed ID: 28744662
    [No Abstract]   [Full Text] [Related]  

  • 12. Human papilloma virus vaccination and dysautonomia: Considerations for autoantibody evaluation and HLA typing.
    Hendrickson JE; Tormey CA
    Vaccine; 2016 Aug; 34(38):4468. PubMed ID: 27553747
    [No Abstract]   [Full Text] [Related]  

  • 13. On vaccination programs in the EU Member States: the case of the human papilloma virus.
    Lorente R; Antonanzas F
    Eur J Health Econ; 2017 Sep; 18(7):801-803. PubMed ID: 27928744
    [No Abstract]   [Full Text] [Related]  

  • 14. Understanding Clinic Practices for Human Papilloma Virus Vaccination Series Completion in Clinics That Provide Primary Care: Survey of Clinic Managers in Iowa.
    Askelson NM; Edmonds SW; Momany ET; Tegegne MA
    Sex Transm Dis; 2016 Jul; 43(7):445-9. PubMed ID: 27322047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization Campaigns and Strategies against Human Papillomavirus in Italy: The Results of a Survey to Regional and Local Health Units Representatives.
    Trucchi C; Costantino C; Restivo V; Bertoncello C; Fortunato F; Tafuri S; Amicizia D; Martinelli D; Paganino C; Piazza MF; Tassinari F; Tisa V; Stefanizzi P; Baldo V; Casuccio A; Prato R; Ansaldi F; Icardi G
    Biomed Res Int; 2019; 2019():6764154. PubMed ID: 31355274
    [No Abstract]   [Full Text] [Related]  

  • 16. Bivalent Human Papillomavirus Vaccine Effectiveness in a Japanese Population: High Vaccine-Type-Specific Effectiveness and Evidence of Cross-Protection.
    Kudo R; Yamaguchi M; Sekine M; Adachi S; Ueda Y; Miyagi E; Hara M; Hanley SJB; Enomoto T
    J Infect Dis; 2019 Jan; 219(3):382-390. PubMed ID: 30299519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting of adverse events following immunizations in Ghana - Using disproportionality analysis reporting ratios.
    Ankrah DNA; Darko DM; Sabblah G; Mantel-Teeuwisse A; Leufkens HMG
    Hum Vaccin Immunother; 2018 Jan; 14(1):172-178. PubMed ID: 29172941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Papilloma Virus Vaccination Among Adolescents in a Community Clinic Before and After Intervention.
    Varman M; Sharlin C; Fernandez C; Vasudevan J; Wichman C
    J Community Health; 2018 Jun; 43(3):455-458. PubMed ID: 29368102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine.
    Wattigney WA; Mootrey GT; Braun MM; Chen RT
    Pediatrics; 2001 May; 107(5):E83. PubMed ID: 11331733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High HPV vaccination uptake rates for adolescent girls after regional governmental funding in Shiki City, Japan.
    Hayashi Y; Shimizu Y; Netsu S; Hanley S; Konno R
    Vaccine; 2012 Aug; 30(37):5547-50. PubMed ID: 22749837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.